Opus Genetics, Inc. Accounts Payable
Opus Genetics, Inc. (IRD) had Accounts Payable of $1.88 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $1.88M.
- 2026-03-31: Accounts Payable, Current $4.42M.
- 2025-12-31: Accounts Payable, Current $3.29M.
- 2025-09-30: Accounts Payable, Current $2.40M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.88M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $4.42M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $3.29M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $2.40M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.47M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.43M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $3.15M 10-K · filed 2026-03-12 |
| 2024-09-30 | $844.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $634.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $2.06M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $2.15M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.89M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.32M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $2.22M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.07M 10-K · filed 2024-03-08 |
| 2022-09-30 | $1.47M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $1.89M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.58M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.58M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.43M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.50M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.42M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $1.21M 10-K · filed 2022-03-24 |
| 2019-12-31 | $342.00K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |